2019 American Transplant Congress » Poster Session B: Kidney Immunosuppression: Induction Therapy

6:00pm-7:00pm

Alemtuzumab Induction in Living Donor Renal Transplantation

O. Witkowsky, H. Winters, K. Washburn, G. Bumgardner, A. Rajab, A. El-Hinnawi, T. Pesavento

6:00pm-7:00pm

Alemtuzumab versus Anti-Thymocyte Globulin Induction in the Setting of Immediate Post-Renal Transplant Acute Tubular Necrosis in an Urban, Minority Patient Population

K. Tejani, E. Benedetti, A. Lichvar

6:00pm-7:00pm

Alemtuzumab versus Antithymocyte Globulin Induction Immunosuppression in Highly Sensitized Kidney Transplant Recipients

A. Brueckner¹, E. Yanqui¹, C. Truong¹, R. Baliga², L. Bowman¹

6:00pm-7:00pm

Basiliximab vs. Low-Dose Thymoglobulin Induction Therapy in Low Risk Kidney Transplant Patients: Prospective Randomized Study in Southeastern Mexico

G. Martinez-Mier, P. I. Moreno-Ley, L. F. Budar-Fernandez, M. T. Mendez-Lopez, D. A. Barrera-Amoros, M. De la Paz-Roman, L. A. Jimenez-López, E. G. Aguilar-Sandoval, C. A. Allende-Castellanos

6:00pm-7:00pm

Combined Antithymocyte Globulin (ATG) and Rituximab (RTX) Induction in African American (AA) Kidney Transplant Recipients

S. J. Patel, S. Kuten, C. Pham, R. Knight, M. Hobeika, D. Nguyen, E. Graviss, S. Yi, T. Eagar, A. Gaber

6:00pm-7:00pm

Comparing the Rate of Opportunistic Infection after Renal Transplant between Alemtuzumab and Basiliximab for Induction Immunosuppression

J. A. Seaman¹, S. G. Westphal², F. Qiu³, D. Bremers⁴, D. Florescu⁵

6:00pm-7:00pm

Evaluation of Induction Immunosuppression in Elderly Kidney Transplant Recipients

C. Pham, S. Kuten, A. Rogers, R. Knight, D. T. Nguyen, E. Graviss, A. Gaber

6:00pm-7:00pm

Impact Of Rituximab And Maintenance Steroid In The Recurrence Of Focal Segmental Glomerulosclerosis

L. A. Mendez Castaner

6:00pm-7:00pm

Induction Therapy in Elderly Kidney Transplant Recipients with Low Immunological Risk

C. Masset¹, J. Boucquemont², V. Garrigue³, M. Ladrière⁴, F. Buron⁵, E. Cassuto⁶, Y. Foucher², J. Dantal¹

6:00pm-7:00pm

Induction Type Does Not Influence Kidney Graft or Patient Survival in Recipients with a Previous Heart Transplant in the United States

S. M. Riad¹, A. Tamas¹, S. Jackson², C. Martin¹

6:00pm-7:00pm

Induction Type Does Not Influence Kidney Graft or Patient Survival in Recipients with a Previous Lung Transplant in the United States

S. Riad¹, U. Goswami², S. Jackson³, M. Hertz²

6:00pm-7:00pm

Induction with Thymoglobulin in DCD Kidneys. Dose Effect and Predictors of Outcome

A. Asderakis, T. Sabah, A. Jones, E. Ablorsu, L. Szabó, R. Chavez

6:00pm-7:00pm

Kidney Transplantation in Older Recipients with HLA-DR Mismatch: Impact of Induction Type on Outcomes

K. K. Sureshkumar¹, N. L. Thai², B. Chopra¹

6:00pm-7:00pm

Living Donor Renal Transplantation without Any Induction Immunosuppression in Spousal Donors – Single Center Experience

R. Bhat, F. Aziz, I. N. Abubecker, S. Narayanan, B. Hafeeque

6:00pm-7:00pm

Low Dose Anti-Thymocyte Globulin is Enough to Prevent Acute Cellular Rejection in Kidney Transplant

P. W. Baron¹, J. Weissman², F. Fazeli³, C. Zuppan⁴, R. Villicana³, P. Wai¹, L. Beeson⁵, M. De Vera¹

6:00pm-7:00pm

Outcomes Of Dosing Weight Selection On Rabbit Anti-thymocyte Globulin Induction Immunosuppression In High-risk, Obese Renal Transplant Recipients

A. C. Cordry¹, K. Trobaugh¹, L. Ramsey², A. L. Castellanos³, H. Fattah³, T. Rendulic¹

6:00pm-7:00pm

Outcomes of Induction Therapy with Bortezomib and High-Dose Intravenous Immunoglobulin for Kidney Transplantation with Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibodies

Y. Miyauchi, T. Noda, N. Miura, T. Kikugawa, T. Saika

6:00pm-7:00pm

Outcomes of Reduced Thymoglobulin Induction Dosing in Elderly Kidney Transplant Recipients at a Steroid Sparing Center

E. C. Liu, J. H. Lee, R. Abramova

6:00pm-7:00pm

Panel Reactive Antibody Stratification as a Guide to Induction Selection in Deceased-Donor Kidney Transplantation: Impact of Clinical Practice on Outcomes

H. Ibrahim¹, J. Gregg¹, K. Alquadan¹, U. Akanit², K. L. Womer¹, A. H. Santos¹

6:00pm-7:00pm

Safety Outcomes in Elderly Patients Who Receive Alemtuzumab Induction for Kidney Transplant

S. Anders, A. Freeman, A. Mohammed, L. Hutchinson, U. Kaszubski, M. Janusek, J. Garces, H. Bohorquez

6:00pm-7:00pm

Safety and Efficacy of Alemtuzumab Compared to Rabbit Anti-Thymocyte Globulin as Induction for Secondary Transplant after a Primary Transplant with Alemtuzumab Induction

J. L. Fose¹, M. R. Jorgenson¹, G. E. Leverson², R. R. Redfield²

6:00pm-7:00pm

Thymoglobulin Versus Alemtuzumab Induction in High Immunologic Risk Kidney Transplants

J. Lockridge¹, J. Pryor¹, D. Norman¹, A. Olyaei²

6:00pm-7:00pm

Type of Induction Does Not Impact Patient or Kidney Allograft Survival in Simultaneous Liver and Kidney Transplant Recipients in the United States

S. Riad¹, N. Lim², S. Jackson³, J. Lake²